Arkema divests its phosphorus derivatives business

COLOMBES, France, October 28, 2022–(BUSINESS WIRE)–Regulatory News:

Arkema (Paris:AKE):

Arkema announces the planned sale of Febex, a company specializing in phosphorus-based chemistry, to the Belgian group Prayon. Arkema continues its dynamic business portfolio management.

Febex is a global supplier of phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives) mainly used in electronics and pharmaceutical industries. As part of the Performance Additives business and with little integration with the group’s other activities, Febex reported sales of around €30 million in 2021, employs 59 people and operates 1 site in Switzerland.

By joining Prayon, an industrial group specializing in phosphorus chemistry, the Febex teams will benefit from the Belgian group’s growth ambitions in this area.

This project, which is expected to start on 01.01St Quarter 2023, subject to the information and prior consultation process with the employee representatives in France and the approval of the competent Swiss authorities.

Building on its unique expertise in materials science, Arkema offers a portfolio of best-in-class technologies to meet the ever-growing demand for new and sustainable materials. With the aim of becoming a pure player in Specialty Materials by 2024, the Group is organized into three complementary, resilient and highly innovative Specialty Materials segments – Adhesive Solutions, Advanced Materials and Coating Solutions – representing approximately 85.5% of the world market Group sales in 2021 and a well positioned and competitive intermediates segment. Arkema offers state-of-the-art technological solutions to meet the challenges of new energies, access to water, recycling, urbanization and mobility, among others, and promotes an ongoing dialogue with all its stakeholders. The group achieved sales of around 9.5 billion euros in 2021 and is active in around 55 countries with 20,200 employees worldwide.

View source version on


Investor Relations Contacts
Beatrice Zilm +33 (0)1 49 00 75 58 [email protected]
Peter Farren +33 (0)1 49 00 73 12 [email protected]
Mathieu Briatta +33 (0)1 49 00 72 07 [email protected]
Caroline Chung +33 (0)1 49 00 74 37 [email protected]

press contact
Anne Plaisance +33 (0)6 81 87 48 77 [email protected]


Leave a Reply

Your email address will not be published. Required fields are marked *